Decreased staining of heparan sulfate in non-lesional skin of a subgroup of patients with systemic lupus erythematosus

Acta Dermato-Venereologica

Volumn 78, Issue 5, 1998, Pages 326-330

  Seyger, M M B ^a   Van Bruggen, M C J ^a   Hardeman, H K ^a   Van Den Hoogen, F H J ^a   Berden, J H M ^a   Van Den Born, J ^a   De Jong, E M G J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anti DNA antibodies; Basement membrane; Dermal epidermal junction; Immunoglobulin; Lupus nephritis

Indexed keywords

DNA ANTIBODY; HEPARAN SULFATE; IMMUNOGLOBULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; CLINICAL ARTICLE; CORRELATION FUNCTION; FEMALE; GLOMERULUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PRIORITY JOURNAL; SKIN BIOPSY; SKIN EPITHELIUM; STAINING; STRUCTURE ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0031877681     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155598442971     Document Type: Article

References (23)

1. Aiba S, Yoshie O, Tomita Y, Tagami H. Cross-reactivity of murine monoclonal anti-DNA antibodies with human and murine skin: a possible pathogenetic role in skin lesions of lupus erythematosus. J Invest Dermatol 1989; 93: 739-745.
2. Tax WJ, Kramers C, van Bruggen MC, Berden JHM. Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosus [editorial]. Kidney Int 1995; 48: 666-673.
3. Termaat RM, Brinkman K, van Gompel F, van den Heuvel LP, Veerkamp JH, Smeenk-RJ, et al. Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes. J Autoimmun 1990; 3: 531-545.
4. Kramers C, Hylkema MN, van Bruggen MC, van de Lagemaat R, Dijkman HB, Assmann KJ, et al. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest 1994; 94: 568-577.
5. van den Born J, van den Heuvel LP, Bakker MA, Veerkamp JH, Assmann KJ, Weening-JJ, et al. Distribution of GBM heparan sulfate proleoglycan core protein and side chains in human glomerular diseases. Kidney Int 1993; 43: 454-463.
6. van Bruggen MC, Kramers K, Hylkema MN, van den Born J, Bakker MA, Assmann KJ, et al. Decrease of heparan sulfate staining in the glomerular basement membrane in murine lupus nephritis. Am J Pathol 1995; 146: 753-763.
7. van Bruggen MCJ, Kramers C, Walgreen B, Elema JD, Kallenberg CGM, van den Born J, et al. Nucleosomes and histones are present in glomerular deposits in human lupus nephritis. Nephrol Dial Transplant 1997; 12: 57-66.
8. Brown MM, Yount WJ. Skin immunopathology in system lupus erythematosus. JAMA 1980; 243: 38-42.
9. Baart de la Faille Kuyp, Cormane RH. The occurrence of certain serum factors in the dermal epidermal junction and vessel walls of the skin in lupus erythematosus and other (skin) diseases. Acta Derm Venereol (Stockh) 1968; 48: 578-588.
10. Schalkwijk J, van Vlijmen I, Oosterling B, Perret C, Koopman R, van den Born J, et al. Tenascin expression in hyperproliferative skin diseases. Br J Dermatol 1991; 124: 13-20.
11. Tan FM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
12. van den Born J, Gunnarsson K, Bakker MA, Kjellen L, Kusche Gullberg M, Maccarana M, et al. Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody. J Biol Chem 1995; 270: 31303-31309.
13. van den Born J, van den Heuvel LP, Bakker MA, Veerkamp JH, Assmann KJ, Berden JH. A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int 1992; 41: 115-123.
14. van den Born J, van den Heuvel LP, Bakker MA, Veerkamp JH, Assmann KJ, Berden JH. Monoclonal antibodies against the protein core and glycosaminoglycan side chain of glomerular basement membrane heparan sulfate proteoglycan: characterization and immunohistological application in human tissues. J Histochem Cytochem 1994; 42: 89-102.
15. van den Born J, van den Heuvel LP, Bakker MA, Veerkamp JH, Assmann KJ, Berden JH. Production and characterization of a monoclonal antibody against human glomerular heparan sulfate. Lab Invest 1991; 65: 287-297.
16. Seyger MMB, van den Born J, Schalkwijk J, van de Kerkhof PCM, de Jong EMGJ. Altered distribution of heparan sulfate proteoglycans in psoriasis. Acta Derm Venereol (Stockh) 1997; 77: 105-109.
17. Seyger MMB, van Pelt JPA, van den Born J, Latijnhouwers MA, de Jong EMGJ. Epicutaneous application of leukotriene B4 induces patterns of tenascin and a heparan sulfate proteoglycan epitope that are typical for psoriatic lesions. Arch Dermatol Res 1997; 289: 331-336.
18. Provost TT, Andres G, Maddison PJ, Reichlin M. Lupus band test in untreated SLE patients: correlation of immunoglobulin deposition in the skin of the extensor forearm with clinical renal disease and serological abnormalities. J Invest Dermatol 1980; 74: 407-412.
19. Sontheimer RD, Gilliam JN. A reappraisal of the relationship between subepidermal immunoglobulin deposits and DNA antibodies in systemic lupus erythematosus: a study using the Crithidia luciliae immunofluorescence anti-DNA assay. J Invest Dermatol 1979; 72: 29-32.
20. Landry M, Sams WM Jr. Basement-membrane antibodies in two patients with systemic lupus erythematosus. Lancet 1972; 1: 821-822.
21. Gilliam JN. The significance of cutaneous immunoglobulin deposits in lupus erythematosus and NZB/NZW F1 hybrid mice. J Invest Dermatol 1975; 65: 154-161.
22. Furukawa F, Ohshio G, Imamura S. Pathogenesis of lupus dermatoses in autoimmune mice. XIX. Attempts to induce subepidermal immunoglobulin deposition in MRL/Mp- +/+ mice. Arch Dermatol Res 1993; 285: 20-26.
23. Raats CJ, Bakker MA, van den Born J, Berden JH. Hydroxyl radicals depolymerize glomerular heparan sulfate in vitro and in experimental nephrotic syndrome. J Biol Chem 1997; 272: 26734-26741.